Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel
View all
Berkeley Lights
Series E • Emeryville, United States
Synthego
Series E • Redwood City, United States
Omada Health
Series E • San Francisco, United States
Guideline
Series E • San Mateo, United States
98point6
Series E • Seattle, United States
Aviatrix
Series E • Santa Clara, United States
BetterUp
Series E • San Francisco, United States
Travere Therapeutics
Post IPO Debt • San Diego, United States
Bolt Threads
Series E • Emeryville, United States
Akebia Therapeutics
Post IPO Equity • Cambridge, United States
Globality
Series E • Menlo Park, United States
Expel
Series E • Herndon, United States